In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus‐related antigens in hepatocellular carcinoma

The overwhelming evidence that chronic infection with the hepatitis C virus (HCV) is an important cause of hepatocellular carcinoma (HCC) is based on epidemiologic, case‐control, and cohort studies as well as laboratory investigations. To address better the pathogenesis of HCV infection at the single‐cell level, the authors developed a specific reproducible method for the simultaneous detection of HCV specific sequences and antigens in liver tissue, using a combination of nonradioactive in situ hybridization and immunohistochemistry.

[1]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[2]  K. Meyer,et al.  Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype , 1996, Journal of virology.

[3]  R. Purcell,et al.  Hepatitis C virus: Detection of intracellular virus particles by electron microscop , 1996 .

[4]  N. Enomoto,et al.  Detection of hepatitis C virus RNA in hepatocellular carcinoma by in situ hybridization , 1995, Cancer.

[5]  F. Chisari,et al.  Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR , 1995, Journal of virology.

[6]  M. Lai,et al.  Differential subcellular localization of hepatitis C virus core gene products. , 1995, Virology.

[7]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[8]  T. Crook,et al.  Viral infection and cancer , 1995, The Lancet.

[9]  T. Takegami,et al.  Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells , 1995, Journal of virology.

[10]  M. Bernardi,et al.  Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patient , 1995, Cancer.

[11]  F. Giostra,et al.  Hepatocellular codistribution of c100, c33, c22, and NS5 hepatitis C virus antigens detected by using immunopurified polyclonal spontaneous human antibodies , 1995, Hepatology.

[12]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[13]  D. Sansonno,et al.  Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus–infected patients with mixed cryoglobulinemia , 1995, Hepatology.

[14]  M. Di Stasi,et al.  Demonstration and distribution of HCV RNA sequences by in situ hybridization and HCV-related proteins by immunohistochemistry in the liver tissue of patients with chronic HCV infection. , 1995, Pathobiology : journal of immunopathology, molecular and cellular biology.

[15]  D. Sansonno,et al.  Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. , 1994, Blood.

[16]  N. Hayashi,et al.  Expression of hepatitis C virus in hepatocellular carcinoma , 1994, Cancer.

[17]  G. Bishop,et al.  False detection of negative-strand hepatitis C virus RNA , 1994, The Lancet.

[18]  T. Date,et al.  Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis , 1994, Hepatology.

[19]  H. Blum Does hepatitis C virus cause hepatocellular carcinoma? , 1994, Hepatology.

[20]  K. Isono,et al.  Detection of minus‐strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma , 1994, Cancer.

[21]  N. Enomoto,et al.  Detection of hepatitis C virus RNA in the liver by in situ hybridization. , 2008, Liver.

[22]  E. Schiff,et al.  Viral pathogenesis of hepatocellular carcinoma in the United States , 1993, Hepatology.

[23]  C. Kim,et al.  Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B‐endemic area , 1993 .

[24]  S. Chen,et al.  Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells , 1993, Journal of virology.

[25]  D. Sansonno,et al.  Hepatitis C virus c100 antigen in liver tissue from patients with acute and chronic infection , 1993, Hepatology.

[26]  R. Purcell,et al.  Correlation between the infectivity of hepatitis C virus in vivo and its infectivity in vitro. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Tsukuma,et al.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.

[28]  M. Houghton,et al.  Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. , 1993, The Journal of general virology.

[29]  C. Bréchot,et al.  Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg‐Negative Patients: A Study of a Low‐endemic Area , 1993, Hepatology.

[30]  K. Blight,et al.  Detection of hepatitis C virus RNA by in situ hybridization. , 2008, Liver.

[31]  S. Thung,et al.  Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma. , 1992, The American journal of pathology.

[32]  A. Nakao,et al.  Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus‐strand and minus‐strand viral RNA , 1992, Cancer.

[33]  B. Sangro,et al.  Hepatitis B and C viral infections in patients with hepatocellular carcinoma , 1992, Hepatology.

[34]  M. Alter,et al.  Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. , 1992, Gastroenterology.

[35]  R. Purcell,et al.  Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Okamoto,et al.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. , 1992, The Journal of general virology.

[37]  T. Koji,et al.  Detection of hepatitis C virus (HCV) RNA in paraffin embedded tissue sections of human liver of non‐A, non‐B hepatitis patients by in situ hybridization , 1992, Journal of clinical laboratory analysis.

[38]  E. Schiff,et al.  Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[39]  D. Sansonno,et al.  Correlation between hepatitis B core antigen in liver tissue and hepatitis B virus DNA in the serum of HBV-infection chronic carriers. , 1987, Archives of pathology & laboratory medicine.

[40]  C. Muir,et al.  Estimates of the worldwide frequency of twelve major cancers. , 1984, Bulletin of the World Health Organization.

[41]  V. Stollar,et al.  Studies on the nature of dengue viruses. III. RNA synthesis in cells infected with type 2 dengue virus. , 1967, Virology.